Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-127.46	-99.56	41.96	15.91	41.98	145.52
Depreciation & Amortization	89.99	78.79	75.57	81	28.55	19.91
Other Amortization	3.47	3.22	3.75	7.21	25.91	20.41
Loss (Gain) From Sale of Assets	-	-	-	-	-	0.02
Asset Writedown & Restructuring Costs	163.24	163.24	-	36.63	-	-
Loss (Gain) From Sale of Investments	11	-	-	10	-	-1.62
Stock-Based Compensation	55.52	51.17	47.9	48.09	42.25	39.92
Other Operating Activities	-2.02	11.05	31.25	-37.14	12.55	-113.34
Change in Accounts Receivable	-9.57	-7.75	-7.16	-2.08	-10.43	-5.52
Change in Inventory	-44.72	-20.93	-8.29	2.49	-4.47	-6.35
Change in Accounts Payable	9.66	3.08	0.92	6.27	-10.26	-3.31
Change in Other Net Operating Assets	-14.59	7.07	-31.24	-23.11	-0.35	-18.61
Operating Cash Flow	134.52	189.39	154.65	145.27	125.72	77.03
Operating Cash Flow Growth	-30.79%	22.46%	6.45%	15.56%	63.20%	9.23%
Capital Expenditures	-17.46	-10.64	-15.16	-30.08	-45.87	-37.8
Cash Acquisitions	-16.7	-	-	-32	-424.04	-
Investment in Securities	18.16	-72.64	92.7	-163.11	449.12	-239.81
Investing Cash Flow	-16	-83.28	77.54	-225.19	-20.79	-277.61
Long-Term Debt Issued	-	287.5	149.55	-	363.75	314.71
Long-Term Debt Repaid	-	-210.89	-330.31	-427.69	-	-176.79
Net Debt Issued (Repaid)	-12.19	76.62	-180.76	-427.69	363.75	137.92
Issuance of Common Stock	2.5	2.3	4.75	27.34	26.66	135.56
Repurchase of Common Stock	-55.61	-25.49	-0.11	-	-	-33.09
Other Financing Activities	-	-36.06	-6.91	-1.18	-9.71	-18.08
Financing Cash Flow	-65.3	17.36	-183.03	-401.53	380.69	222.3
Net Cash Flow	53.43	123.48	49.16	-481.44	485.62	21.73
Free Cash Flow	117.07	178.75	139.49	115.2	79.85	39.23
Free Cash Flow Growth	-36.63%	28.15%	21.09%	44.27%	103.54%	-35.01%
Free Cash Flow Margin	16.59%	25.50%	20.67%	17.28%	14.74%	9.13%
Free Cash Flow Per Share	2.54	3.87	2.68	2.48	1.75	0.90
Cash Interest Paid	16.12	15.42	27.64	33.3	7	7.21
Cash Income Tax Paid	14.59	11.02	4.37	7.4	3.22	2.42
Levered Free Cash Flow	108.49	163.38	107.15	92	49.79	38.75
Unlevered Free Cash Flow	116.67	170.52	116.09	109.78	43.72	34.39
Change in Working Capital	-59.22	-18.52	-45.78	-16.43	-25.51	-33.8

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q